{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T10:54:18Z","timestamp":1787482458117,"version":"build-2736575974"},"reference-count":42,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008484","name":"BioMarin Pharmaceutical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.taap.2014.03.005","type":"journal-article","created":{"date-parts":[[2014,3,20]],"date-time":"2014-03-20T01:15:51Z","timestamp":1395278151000},"page":"49-57","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Recombinant human tripeptidyl peptidase-1 infusion to the monkey CNS: Safety, pharmacokinetics, and distribution"],"prefix":"10.1016","volume":"277","author":[{"given":"Brian R.","family":"Vuillemenot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randall P.","family":"Reed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert B.","family":"Boyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark T.","family":"Butt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald G.","family":"Musson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Keve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhea","family":"Cahayag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurie S.","family":"Tsuruda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles A.","family":"O'Neill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2014.03.005_bb0005","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/pr.2011.13","article-title":"Intrathecal recombinant human 4-sulphatase reduces accumulation of glycosaminoglycans in dura of mucopolysaccharidosis VI cats","volume":"71","author":"Auclair","year":"2012","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.taap.2014.03.005_bb0010","doi-asserted-by":"crossref","first-page":"e4792","DOI":"10.1371\/journal.pone.0004792","article-title":"A plant-derived recombinant human glucocerebrosidase enzyme \u2014 a preclinical and phase I investigation","volume":"4","author":"Aviezer","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.taap.2014.03.005_bb0015","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ymgme.2005.04.013","article-title":"Penetration, diffusion, and uptake of recombinant human alpha-l-iduronidase after intraventricular injection into the rat brain","volume":"86","author":"Belichenko","year":"2005","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.taap.2014.03.005_bb0020","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ymgme.2007.08.124","article-title":"CLN2\/TPP1 deficiency: the novel mutation IVS7-10A>G causes intron retention and is associated with a mild disease phenotype","volume":"93","author":"Bessa","year":"2008","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.taap.2014.03.005_bb0025","first-page":"R889","article-title":"Raised intracranial pressure increases CSF drainage through arachnoid villi and extracranial lymphatics","volume":"275","author":"Boulton","year":"1998","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.taap.2014.03.005_bb0030","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.brainresrev.2010.08.002","article-title":"Recent insights into a new hydrodynamics of the cerebrospinal fluid","volume":"65","author":"Bulat","year":"2011","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.taap.2014.03.005_bb0035","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1177\/0192623310391679","article-title":"Morphologic changes associated with intrathecal catheters for direct delivery to the central nervous system in preclinical studies","volume":"39","author":"Butt","year":"2011","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.taap.2014.03.005_bb0040","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/mt.2008.9","article-title":"Intraventricular enzyme replacement improves disease phenotypes in a mouse model of late infantile neuronal ceroid lipofuscinosis","volume":"16","author":"Chang","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.taap.2014.03.005_bb0050","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1526-4637.2006.00150.x","article-title":"Inflammatory mass of an intrathecal catheter in patients receiving baclofen as a sole agent: a report of two cases and a review of the identification and treatment of the complication","volume":"8","author":"Deer","year":"2007","journal-title":"Pain Med."},{"key":"10.1016\/j.taap.2014.03.005_bb0055","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ymgme.2006.12.012","article-title":"Intrathecal enzyme replacement therapy: successful treatment of brain disease via the cerebrospinal fluid","volume":"91","author":"Dickson","year":"2007","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.taap.2014.03.005_bb0060","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1006\/exnr.1996.0157","article-title":"Pharmacokinetics of intrathecally applied BDNF and effects on spinal motoneurons","volume":"141","author":"Dittrich","year":"1996","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.taap.2014.03.005_bb0065","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00401-008-0349-3","article-title":"Atypical CLN2 with later onset and prolonged course: a neuropathologic study showing different sensitivity of neuronal subpopulations to TPP1 deficiency","volume":"116","author":"Elleder","year":"2008","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.taap.2014.03.005_bb0070","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1177\/0192623311409595","article-title":"Safety evaluation of chronic intrathecal administration of idursulfase-IT in cynomolgus monkeys","volume":"39","author":"Felice","year":"2011","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.taap.2014.03.005_bb0075","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.nbd.2009.07.028","article-title":"Approaches to transport therapeutic drugs across the blood\u2013brain-barrier to treat brain diseases","volume":"37","author":"Gabathuler","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.taap.2014.03.005_bb0080","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1093\/cercor\/6.4.551","article-title":"Quantitative magnetic resonance imaging of human brain development: ages 4\u201318","volume":"6","author":"Giedd","year":"1996","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.taap.2014.03.005_bb0085","doi-asserted-by":"crossref","first-page":"31058","DOI":"10.1074\/jbc.M400700200","article-title":"Maturation of human tripeptidyl-peptidase I in vitro","volume":"279","author":"Golabek","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.taap.2014.03.005_bb0090","first-page":"630","article-title":"Intraventricular vancomycin-induced cerebrospinal fluid eosinophilia: report of two patients","volume":"30","author":"Grabb","year":"1992","journal-title":"Neurosurgery"},{"key":"10.1016\/j.taap.2014.03.005_bb0095","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1074\/jbc.M806943200","article-title":"Crystal structure and autoactivation apthway of the precursor form of human tripeptidyl-peptidase 1, the enzyme deficient in late infantile ceroid lipofuscinosis","volume":"284","author":"Guhaniyogi","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.taap.2014.03.005_bb0100","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1055\/s-0029-1202359","article-title":"Formation of two consecutive intrathecal catheter tip granulomas within nine months","volume":"71","author":"Hoederath","year":"2010","journal-title":"Cent. Eur. Neurosurg."},{"key":"10.1016\/j.taap.2014.03.005_bb0105","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1177\/01926230701481899a","article-title":"Six-month continuous intraputamenal infusion toxicity study of recombinant methionyl human glial cell line-derived neurotrophic factor (r-metHuGDNF) in rhesus monkeys","volume":"35","author":"Hovland","year":"2007","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.taap.2014.03.005_bb0110","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1086\/316953","article-title":"Fabry disease: preclinical studies demonstrate the effectiveness of alpha-galactosidase A replacement in enzyme-deficient mice","volume":"68","author":"Iannou","year":"2001","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.taap.2014.03.005_bb0115","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.bbamcr.2008.11.004","article-title":"Neuronal ceroid lipofuscinoses","volume":"1793","author":"Jalanko","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.taap.2014.03.005_bb0125","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ymgme.2009.08.003","article-title":"Cross-reactive immunologic material status affects treatment outcomes in Pompe disease infants","volume":"99","author":"Kishnani","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.taap.2014.03.005_bb0130","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1042\/bj3570049","article-title":"Production and characterization of recombinant human CLN2 protein for enzyme-replacement therapy in late infantile neuronal ceroid lipofuscinosis","volume":"357","author":"Lin","year":"2001","journal-title":"Biochem. J."},{"key":"10.1016\/j.taap.2014.03.005_bb0135","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1097\/00006123-198611000-00022","article-title":"Eosinophilia of the cerebrospinal fluid in a case of shunt infection: case report","volume":"19","author":"Mine","year":"1986","journal-title":"Neurosurgery"},{"key":"10.1016\/j.taap.2014.03.005_bb0140","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1002\/ajmg.a.32294","article-title":"Intrathecal enzyme replacement therapy in a patient with mucopolysaccharidosis type I and symptomatic spinal cord compression","volume":"146A","author":"Munoz-Rojas","year":"2008","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.taap.2014.03.005_bb0145","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/jb\/mvi110","article-title":"Catalytic residues and substrate specificity of recombinant human tripeptidyl peptidase I (CLN2)","volume":"138","author":"Oyama","year":"2005","journal-title":"J. Biochem."},{"key":"10.1016\/j.taap.2014.03.005_bb0150","series-title":"Peptide Drug Delivery to the Brain","author":"Pardridge","year":"1991"},{"key":"10.1016\/j.taap.2014.03.005_bb0155","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1743-8454-7-9","article-title":"The function and structure of the cerebrospinal fluid outflow system","volume":"7","author":"Pollay","year":"2010","journal-title":"Cerebrospinal Fluid Res."},{"key":"10.1016\/j.taap.2014.03.005_bb0160","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1200\/JCO.2006.09.7311","article-title":"Phase I study of intraventricular administration of rituximab in patients with recurrent CNS and intraocular lymphoma","volume":"25","author":"Rubenstein","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.taap.2014.03.005_bb0165","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s11060-009-9998-x","article-title":"Pharmacokinetic analysis of etopside distribution after administration directly into the fourth ventricle in a piglet model","volume":"97","author":"Sandberg","year":"2009","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.taap.2014.03.005_bb0170","doi-asserted-by":"crossref","first-page":"12937","DOI":"10.1073\/pnas.91.26.12937","article-title":"Enzyme replacement in a canine model of Hurler syndrome","volume":"91","author":"Shull","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.taap.2014.03.005_bb0175","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ymgme.2008.01.014","article-title":"Residual levels of tripeptidyl-peptidase I activity dramatically ameliorate disease in late-infantile neuronal ceroid lipofuscinosis","volume":"94","author":"Sleat","year":"2008","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.taap.2014.03.005_bb0180","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1046\/j.1471-4159.1999.0730700.x","article-title":"Biochemical characterization of a lysosomal protease deficient in classical late infantile neuronal ceroid lipofuscinosis (LINCL) and development of an enzyme-based assay for diagnosis and exclusion of LINCL in human specimens and animal models","volume":"73","author":"Sohar","year":"1999","journal-title":"J. Neurochem."},{"key":"10.1016\/j.taap.2014.03.005_bb0185","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00280-010-1522-7","article-title":"Safety and pharmacokinetics of intrathecal administration of pemetrexed in rats","volume":"68","author":"Sun","year":"2010","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.taap.2014.03.005_bb0190","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/j.1749-6632.2002.tb07588.x","article-title":"Surface-based atlases of cerebellar cortex in the human, macaque, and mouse","volume":"978","author":"Van Essen","year":"2002","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.taap.2014.03.005_bb0195","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.ymgme.2011.03.011","article-title":"Biodistribution and pharmacodynamics of recombinant human alpha-l-iduronidase (rhIDU) in mucopolysaccharidosis type I-affected cats following multiple intrathecal administrations","volume":"103","author":"Vite","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.taap.2014.03.005_bb0200","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.ymgme.2011.06.018","article-title":"Intrathecal tripeptidyl-peptidase 1 reduces lysosomal storage in a canine model of late infantile neuronal ceroid lipofuscinosis","volume":"104","author":"Vuillemenot","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.taap.2014.03.005_bb0210","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1472-6807-3-8","article-title":"A model of tripeptidyl-peptidase I (CLN2), a ubiquitous and highly conserved member of the sedolisin family of serine-carboxyl peptidases","volume":"3","author":"Wlodawer","year":"2003","journal-title":"BMC Struct. Biol."},{"key":"10.1016\/j.taap.2014.03.005_bb0215","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1006\/faat.1997.2314","article-title":"Kinetic and safety studies on intrathecally infused recombinant-methionyl human brain-derived neurotropic factor in dogs","volume":"38","author":"Yaksh","year":"1997","journal-title":"Fundam. Appl. Toxicol."},{"key":"10.1016\/j.taap.2014.03.005_bb0220","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1093\/toxsci\/kfh168","article-title":"Intrathecal ketorolac in dogs and rats","volume":"80","author":"Yaksh","year":"2004","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.taap.2014.03.005_bb0225","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.expneurol.2011.06.019","article-title":"Distribution of acid sphingomyelinase in rodent and non-human primate brain after intracerebroventricular infusion","volume":"23","author":"Ziegler","year":"2011","journal-title":"Exp. Neurol."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X1400091X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X1400091X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T20:42:35Z","timestamp":1758573755000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X1400091X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S0041008X1400091X"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2014.03.005","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recombinant human tripeptidyl peptidase-1 infusion to the monkey CNS: Safety, pharmacokinetics, and distribution","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2014.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}